[Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis]
- PMID: 17439069
[Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis]
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease characterized by fibrosis in the lung parenchyma and collagen deposition leading to respiratory failure. Different etiopathogenetic hypothesis have been formulated during the last years and many studies recently published demonstrated that in most of processes suggested for the onset and the development of IPF, chemokines and chemokine receptors are involved. Dysregulated expression of chemokines and their receptors during inflammatory processes might also alter the equilibrium between angiostatic and angiogenic processes leading to neovascularization in the lung tissue. Studies on chemokines/chemokine receptors could shed light on the mechanisms involved in IPF and draw new therapeutic strategies to block the progression of the disease.
Similar articles
-
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.J Immunol. 1997 Aug 1;159(3):1437-43. J Immunol. 1997. PMID: 9233641
-
CXC chemokines in vascular remodeling related to pulmonary fibrosis.Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S67-9. Am J Respir Cell Mol Biol. 2003. PMID: 14503558 Review. No abstract available.
-
Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.Proc Am Thorac Soc. 2006 Jun;3(4):357-63. doi: 10.1513/pats.200601-010TK. Proc Am Thorac Soc. 2006. PMID: 16738201 Review.
-
The role of chemokines in the immunopathology of pulmonary disease.Forum (Genova). 1999 Oct-Dec;9(4):339-55. Forum (Genova). 1999. PMID: 10611410 Review.
-
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.Am J Respir Crit Care Med. 2005 Feb 1;171(3):261-8. doi: 10.1164/rccm.200409-1164OC. Epub 2004 Oct 22. Am J Respir Crit Care Med. 2005. PMID: 15502109
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical